Library › Molecules › Approved drugs · Digestive & metabolic
Approved drugs · Digestive & metabolic: 127 3D models
Water, gases, sugars, nucleotides, amino acids, ions (real sizes 0.1–1 nm). Each one is a ready-made 3D model you can turn, recolour and place in a figure — open BioDioRama and type its name in the Library search.
- Troglitazone — Approved medicine — drugs used in diabetes, first approved 1997. C24H27NO5S, 441.55 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Olsalazine — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents, first approved 1990. C14H10N2O6, 302.24 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Cimetidine — Approved medicine — drugs for acid related disorders, first approved 1977. C10H16N6S, 252.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tolrestat — Approved medicine — drugs used in diabetes, first approved 1989. C16H14F3NO3S, 357.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Glyburide — Approved medicine — drugs used in diabetes, first approved 1984. C23H28ClN3O5S, 494.01 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Lansoprazole — Approved medicine — drugs for acid related disorders, first approved 1995. C16H14F3N3O2S, 369.37 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Pirenzepine — Approved medicine — drugs for acid related disorders. C19H21N5O2, 351.41 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Chlorpropamide — Approved medicine — drugs used in diabetes, first approved 1958. C10H13ClN2O3S, 276.75 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Clotrimazole — Approved medicine — stomatological preparations, first approved 1975. C22H17ClN2, 344.85 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Rimonabant — Approved medicine — antiobesity preparations, excl. diet products, first approved 2006. C22H21Cl3N4O, 463.8 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Rosiglitazone — Approved medicine — drugs used in diabetes, first approved 1999. C18H19N3O3S, 357.44 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Cysteamine — Approved medicine — other alimentary tract and metabolism products, first approved 1994. C2H7NS, 77.15 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Trientine — Approved medicine — other alimentary tract and metabolism products, first approved 1985. C6H18N4, 146.24 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Prednisone — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents, first approved 1955. C21H26O5, 358.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Glycerin — Approved medicine — drugs for constipation, first approved 1982. C3H8O3, 92.09 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Mebeverine — Approved medicine — drugs for functional gastrointestinal disorders. C25H35NO5, 429.56 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Mazindol — Approved medicine — antiobesity preparations, excl. diet products, first approved 1973. C16H13ClN2O, 284.75 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Nateglinide — Approved medicine — drugs used in diabetes, first approved 2000. C19H27NO3, 317.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Granisetron — Approved medicine — antiemetics and antinauseants, first approved 1993. C18H24N4O, 312.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Buformin — Approved medicine — drugs used in diabetes. C6H15N5, 157.22 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tolazamide — Approved medicine — drugs used in diabetes, first approved 1966. C14H21N3O3S, 311.41 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Lactulose — Approved medicine — drugs for constipation, first approved 1976. C12H22O11, 342.3 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Danthron — Approved medicine — drugs for constipation. C14H8O4, 240.21 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Lonafarnib — Approved medicine — other alimentary tract and metabolism products, first approved 2020. C27H31Br2ClN4O2, 638.83 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Glutamine — Approved medicine — other alimentary tract and metabolism products, first approved 2004. C5H10N2O3, 146.15 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tropisetron — Approved medicine — antiemetics and antinauseants. C17H20N2O2, 284.36 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Bisacodyl — Approved medicine — drugs for constipation, first approved 2004. C22H19NO4, 361.4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Phenolphthalein — Approved medicine — drugs for constipation. C20H14O4, 318.33 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tegaserod — Approved medicine — drugs for constipation, first approved 2002. C16H23N5O, 301.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Miglustat — Approved medicine — other alimentary tract and metabolism products, first approved 2002. C10H21NO4, 219.28 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Prasterone — Approved medicine — anabolic agents for systemic use. C19H28O2, 288.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Amlexanox — Approved medicine — stomatological preparations, first approved 1996. C16H14N2O4, 298.3 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Alosetron — Approved medicine — drugs for functional gastrointestinal disorders, first approved 2000. C17H18N4O, 294.36 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Proglumide — Approved medicine — drugs for acid related disorders. C18H26N2O4, 334.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Dicyclomine — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1950. C19H35NO2, 309.49 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Niacinamide — Approved medicine — vitamins, first approved 1982. C6H6N2O, 122.13 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Migalastat — Approved medicine — other alimentary tract and metabolism products, first approved 2016. C6H13NO4, 163.17 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Levocarnitine — Approved medicine — other alimentary tract and metabolism products, first approved 1985. C7H15NO3, 161.2 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Prucalopride — Approved medicine — drugs for constipation, first approved 2009. C18H26ClN3O3, 367.88 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Sulfaguanidine — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents. C7H10N4O2S, 214.25 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Rabeprazole — Approved medicine — drugs for acid related disorders, first approved 1999. C18H21N3O3S, 359.45 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Vildagliptin — Approved medicine — drugs used in diabetes, first approved 2007. C17H25N3O2, 303.41 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Repaglinide — Approved medicine — drugs used in diabetes, first approved 1997. C27H36N2O4, 452.6 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Nitisinone — Approved medicine — other alimentary tract and metabolism products, first approved 2002. C14H10F3NO5, 329.23 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Phenformin — Approved medicine — drugs used in diabetes. C10H15N5, 205.26 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Lorcaserin — Approved medicine — antiobesity preparations, excl. diet products, first approved 2012. C11H14ClN, 195.69 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Paromomycin — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents, first approved 1969. C23H45N5O14, 615.63 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Gliclazide — Approved medicine — drugs used in diabetes. C15H21N3O3S, 323.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Domperidone — Approved medicine — drugs for functional gastrointestinal disorders. C22H24ClN5O2, 425.92 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Methscopolamine — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1953. C18H24NO4+, 318.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Alogliptin — Approved medicine — drugs used in diabetes, first approved 2013. C18H21N5O2, 339.4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Seladelpar — Approved medicine — bile and liver therapy, first approved 2024. C21H23F3O5S, 444.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Aprepitant — Approved medicine — antiemetics and antinauseants, first approved 2003. C23H21F7N4O3, 534.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Linagliptin — Approved medicine — drugs used in diabetes, first approved 2011. C25H28N8O2, 472.55 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Chenodiol — Approved medicine — bile and liver therapy, first approved 1983. C24H40O4, 392.58 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Glimepiride — Approved medicine — drugs used in diabetes, first approved 1995. C24H34N4O5S, 490.63 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Oxyphenisatine — Approved medicine — drugs for constipation. C20H15NO3, 317.34 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Benfluorex — Approved medicine — drugs used in diabetes, first approved 1974. C19H20F3NO2, 351.37 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Oxyphencyclimine — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1982. C20H28N2O3, 344.46 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Alvimopan — Approved medicine — drugs for constipation, first approved 2008. C25H32N2O4, 424.54 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Taurursodiol — Approved medicine — bile and liver therapy, first approved 2022. C26H45NO6S, 499.71 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Miglitol — Approved medicine — drugs used in diabetes, first approved 1996. C8H17NO5, 207.23 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Glibornuride — Approved medicine — drugs used in diabetes. C18H26N2O4S, 366.48 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Phentermine — Approved medicine — antiobesity preparations, excl. diet products, first approved 1959. C10H15N, 149.24 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Acetohexamide — Approved medicine — drugs used in diabetes, first approved 1964. C15H20N2O4S, 324.4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Carbenoxolone — Approved medicine — drugs for acid related disorders. C34H50O7, 570.77 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Mepenzolate — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1956. C21H26NO3+, 340.44 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Voglibose — Approved medicine — drugs used in diabetes, first approved 1994. C10H21NO7, 267.28 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Lactitol — Approved medicine — drugs for constipation, first approved 2020. C12H24O11, 344.31 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Cisapride — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1993. C23H29ClFN3O4, 465.95 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Obeticholic acid — Approved medicine — bile and liver therapy, first approved 2016. C26H44O4, 420.63 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Propantheline — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1953. C23H30NO3+, 368.5 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Palonosetron — Approved medicine — antiemetics and antinauseants, first approved 2003. C19H24N2O, 296.41 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Diethylpropion — Approved medicine — antiobesity preparations, excl. diet products, first approved 1959. C13H19NO, 205.3 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Oxandrolone — Approved medicine — anabolic agents for systemic use, first approved 1964. C19H30O3, 306.45 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Oxymetholone — Approved medicine — anabolic agents for systemic use, first approved 1972. C21H32O3, 332.48 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Ethylestrenol — Approved medicine — anabolic agents for systemic use, first approved 1964. C20H32O, 288.48 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Aluminum hydroxide — Approved medicine — drugs for acid related disorders, first approved 1983. H3AlO3, 78 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Homatropine methylbromide — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1943. C17H24BrNO3, 370.29 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Lubiprostone — Approved medicine — drugs for constipation, first approved 2006. C20H32F2O5, 390.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Isopropamide — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1957. C23H33N2O+, 353.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Methantheline — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1951. C21H26NO3+, 340.44 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Oxyphenonium — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1982. C21H34NO3+, 348.51 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Diphenoxylate — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents, first approved 1960. C30H32N2O2, 452.6 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Difenoxin — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents, first approved 1978. C28H28N2O2, 424.54 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Hexocyclium — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1982. C20H33N2O+, 317.5 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Diphemanil — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1982. C20H24N+, 278.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Balsalazide — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents, first approved 2000. C17H15N3O6, 357.32 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tridihexethyl — Approved medicine — drugs for functional gastrointestinal disorders, first approved 1954. C21H36NO+, 318.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Sapropterin — Approved medicine — other alimentary tract and metabolism products, first approved 2007. C9H15N5O3, 241.25 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Carglumic acid — Approved medicine — other alimentary tract and metabolism products, first approved 2003. C6H10N2O5, 190.16 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Clobenzorex — Approved medicine — antiobesity preparations, excl. diet products. C16H18ClN, 259.78 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Phthalylsulfathiazole — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents. C17H13N3O5S2, 403.44 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Alfacalcidol — Approved medicine — vitamins. C27H44O2, 400.65 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Piperidolate — Approved medicine — drugs for functional gastrointestinal disorders. C21H25NO2, 323.44 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Isometheptene — Approved medicine — drugs for functional gastrointestinal disorders. C9H19N, 141.26 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Ertugliflozin — Approved medicine — drugs used in diabetes, first approved 2017. C22H25ClO7, 436.89 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Evogliptin — Approved medicine — drugs used in diabetes, first approved 2015. C19H26F3N3O3, 401.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Bexagliflozin — Approved medicine — drugs used in diabetes, first approved 2023. C24H29ClO7, 464.94 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Pinaverium — Approved medicine — drugs for functional gastrointestinal disorders. C26H41BrNO4+, 511.52 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Ipragliflozin — Approved medicine — drugs used in diabetes, first approved 2013. C21H21FO5S, 404.46 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Vonoprazan — Approved medicine — drugs for acid related disorders, first approved 2022. C17H16FN3O2S, 345.4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Stanozolol — Approved medicine — anabolic agents for systemic use, first approved 1962. C21H32N2O, 328.5 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Racecadotril — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents. C21H23NO4S, 385.49 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Telotristat — Approved medicine — other alimentary tract and metabolism products. C25H22ClF3N6O3, 546.94 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Glycerol phenylbutyrate — Approved medicine — other alimentary tract and metabolism products, first approved 2013. C33H38O6, 530.66 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Naldemedine — Approved medicine — drugs for constipation, first approved 2017. C32H34N4O6, 570.65 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Uridine triacetate — Approved medicine — other alimentary tract and metabolism products, first approved 2015. C15H18N2O9, 370.31 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Eliglustat — Approved medicine — other alimentary tract and metabolism products, first approved 2014. C23H36N2O4, 404.55 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Mefenorex — Approved medicine — antiobesity preparations, excl. diet products. C12H18ClN, 211.74 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Teneligliptin — Approved medicine — drugs used in diabetes. C22H30N6OS, 426.59 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Eluxadoline — Approved medicine — antidiarrheals, intestinal antiinflammatory/antiinfective agents, first approved 2015. C32H35N5O5, 569.66 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Nabilone — Approved medicine — antiemetics and antinauseants, first approved 1985. C24H36O3, 372.55 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Naloxegol — Approved medicine — drugs for constipation, first approved 2014. C34H53NO11, 651.79 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Fosdenopterin — Approved medicine — other alimentary tract and metabolism products, first approved 2021. C10H14N5O8P, 363.22 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Dihydrotachysterol — Approved medicine — vitamins. C28H46O, 398.68 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Dolasetron — Approved medicine — antiemetics and antinauseants, first approved 1997. C19H20N2O3, 324.38 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Sotagliflozin — Approved medicine — drugs used in diabetes, first approved 2019. C21H25ClO5S, 424.95 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Nizatidine — Approved medicine — drugs for acid related disorders, first approved 1988. C12H21N5O2S2, 331.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tenapanor — Approved medicine — drugs for constipation, first approved 2019. C50H66Cl4N8O10S2, 1145.07 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Difemerine — Approved medicine — drugs for functional gastrointestinal disorders. C20H25NO3, 327.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Rolapitant — Approved medicine — antiemetics and antinauseants, first approved 2015. C25H26F6N2O2, 500.48 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Elafibranor — Approved medicine — bile and liver therapy, first approved 2024. C22H24O4S, 384.5 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Magaldrate — Approved medicine — drugs for acid related disorders. H33Al5Mg10O40S2, 1115.32 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Hydrotalcite — Approved medicine — drugs for acid related disorders. CH24Al2Mg6O23, 603.97 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Triheptanoin — Approved medicine — other alimentary tract and metabolism products, first approved 2020. C24H44O6, 428.61 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Odevixibat — Approved medicine — bile and liver therapy, first approved 2021. C37H48N4O8S2, 740.94 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.